Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LBPH

Longboard Pharmaceuticals (LBPH) Stock Price, News & Analysis

Longboard Pharmaceuticals logo

About Longboard Pharmaceuticals Stock (NASDAQ:LBPH)

Key Stats

Today's Range
$59.98
$59.98
50-Day Range
$59.50
$59.98
52-Week Range
$27.35
$60.03
Volume
N/A
Average Volume
1.37 million shs
Market Capitalization
$2.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$60.00
Consensus Rating
Hold

Company Overview

Receive LBPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LBPH Stock News Headlines

H Lundbeck A/S (HLUNAC.XD)
H. Lundbeck A/S (HLUN-A.CO)
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
See More Headlines

LBPH Stock Analysis - Frequently Asked Questions

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) released its quarterly earnings results on Thursday, August, 1st. The company reported ($0.56) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.46) by $0.10.
Read the conference call transcript
.

Longboard Pharmaceuticals (LBPH) raised $75 million in an IPO on Friday, March 12th 2021. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Evercore ISI, Guggenheim Securities and Cantor acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Longboard Pharmaceuticals investors own include JPMorgan Chase & Co. (JPM), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V) and Home Depot (HD).

Company Calendar

Last Earnings
8/01/2024
Today
9/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LBPH
CIK
1832168
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$60.00
Low Price Target
$60.00
Potential Upside/Downside
+0.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.03%
Return on Assets
-30.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.97
Quick Ratio
15.97

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
35.92

Miscellaneous

Outstanding Shares
39,050,000
Free Float
37,234,000
Market Cap
$2.34 billion
Optionable
Optionable
Beta
1.00
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:LBPH) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners